Unity Biotechnology, Inc. Long-Term Debt, Maturity, Year Three
Unity Biotechnology, Inc. had Long-Term Debt, Maturity, Year Three of $8.07 million as of 2021-12-31, per its 10-K filed 2022-03-15.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2022-03-15
- 2021-12-31: Long-Term Debt, Maturity, Year Three $8.07M.
- 2021-09-30: Long-Term Debt, Maturity, Year Three $8.89M.
- 2021-06-30: Long-Term Debt, Maturity, Year Three $8.89M.
- 2021-03-31: Long-Term Debt, Maturity, Year Three $8.89M.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2021-12-31 | $8.07M 10-K · filed 2022-03-15 |
| 2021-09-30 | $8.89M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $8.89M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $8.89M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $12.27M 10-K · filed 2021-03-23 |
| 2020-09-30 | $12.27M 10-Q · filed 2020-11-04 |